Pharyngitis screening: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{VSKP}} | {{CMG}}; {{AE}}{{VSKP}} | ||
==Overview== | ==Overview== | ||
Routine screening for pharyngitis is not recommended. Testing for etiologic agents of pharyngitis should only be done in symptomatic patients. | Routine screening for [[pharyngitis]] is not recommended. Testing for [[etiologic]] [[agents]] of pharyngitis should only be done in [[symptomatic]] patients. | ||
==Screening== | ==Screening== | ||
Screening for etiologic agents of pharyngitis should only be done in symptomatic patients especially | [[Screening]] for [[etiologic]] agents of [[pharyngitis]] should only be done in [[symptomatic]] patients especially populations at risk. Anyone during the winter months is at risk of pharyngitis, especially those aged 5 to 15 years. Screening can be performed using [[rapid antigen detection test]] (RADT) or throat [[culture]]<ref name="pmid19246689">Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST et al. (2009) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=19246689 Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.] ''Circulation'' 119 (11):1541-51. [http://dx.doi.org/10.1161/CIRCULATIONAHA.109.191959 DOI:10.1161/CIRCULATIONAHA.109.191959] PMID: [https://pubmed.gov/19246689 19246689]</ref> | ||
Screening of asymptomatic carriers can be considered in the following cases: | Screening of asymptomatic carriers can be considered in the following cases: | ||
* Recurrent [[group A streptococcal]] pharyngitis among family members | * Recurrent [[group A streptococcal]] pharyngitis among family members | ||
* During an outbreak of [[rheumatic fever]] | * During an [[outbreak]] of [[rheumatic fever]] | ||
* In patients with personal history of [[acute rheumatic fever]] or [[rheumatic heart disease]] | * In patients with a personal history of [[acute rheumatic fever]] or [[rheumatic heart disease]] | ||
==References== | ==References== | ||
Latest revision as of 19:28, 7 December 2020
|
Pharyngitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pharyngitis screening On the Web |
|
American Roentgen Ray Society Images of Pharyngitis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]
Overview
Routine screening for pharyngitis is not recommended. Testing for etiologic agents of pharyngitis should only be done in symptomatic patients.
Screening
Screening for etiologic agents of pharyngitis should only be done in symptomatic patients especially populations at risk. Anyone during the winter months is at risk of pharyngitis, especially those aged 5 to 15 years. Screening can be performed using rapid antigen detection test (RADT) or throat culture[1]
Screening of asymptomatic carriers can be considered in the following cases:
- Recurrent group A streptococcal pharyngitis among family members
- During an outbreak of rheumatic fever
- In patients with a personal history of acute rheumatic fever or rheumatic heart disease
References
- ↑ Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST et al. (2009) Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 119 (11):1541-51. DOI:10.1161/CIRCULATIONAHA.109.191959 PMID: 19246689